Abstract
Phytochemical investigation of the roots of Valeriana officinalis var. latifolia resulted in the isolation and characterization of six new acylated iridoids, (5S,7S,8S,9S)-7-hydroxy-8-isovaleroyloxy-Δ
4,11-dihyronepetalactone (1), (5S,7S,8S,9S)-7-hydroxy-10-isovaleroyloxy-Δ
4,11-dihyronepetalactone (2), (5S,8S,9S)-10-isovaleroyloxy-Δ
4,11-dihyronepetalactone (3), (5S,6S,8S,9R)-6-isovaleroyloxy-Δ
4,11-1,3-diol (4), (5S,6S,8S,9R)-1,3-isovaleroxy-Δ
4,11-1,3-diol (5), and (5S,6S,8S,9R)-3-isovaleroxy-6-isovaleroyloxy-Δ
4,11-1,3-diol (6). Their structures were determined mainly by 1D and 2D NMR spectroscopic techniques. We also report herein for the first time the single crystal X-ray structure of compound 1. In addition, the cytotoxic activities of compounds 1-6 were evaluated against A549 (human lung adenocarcinoma), HCT116 (human colon carcinoma), SK-BR-3 (human breast carcinoma), and HepG2 (human hepatoma) cell lines. Compound 6 showed weak cell growth inhibition of A549, HCT116, SK-BR-3, and HepG2 cells.
Key words
Valeriana officinalis var.
latifolia
- iridoids - Valerianaceae - acylated iridoids